Reducing glucocorticoid duration in anca-associated vasculitis: A pilot trial

We examined whether an 8-week glucocorticoid course in combination with rituximab (RTX) would induce disease remission in patients with AAV.

Source: Seminars in Arthritis and Rheumatism - February 2, 2018 Category: Rheumatology Authors: Eli M. Miloslavsky, John L. Niles, Zachary S. Wallace, Frank B. Cortazar, Ana Fernandes, Karen Laliberte, John H. Stone Source Type: research